-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q2 2024.
- SAB Biotherapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -1.65K %, a 258% decline year-over-year.
- SAB Biotherapeutics, Inc. annual Operating Margin for 2023 was -1.7K %, a 1306% decline from 2022.
- SAB Biotherapeutics, Inc. annual Operating Margin for 2022 was -121 %, a 450% decline from 2021.
- SAB Biotherapeutics, Inc. annual Operating Margin for 2021 was -22 %, a 159% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)